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Coxiella burnetii causes acute Q fever in humans and occasional chronic infections that typically manifest as
endocarditis or hepatitis. Isolates associated with acute disease were found to be distinct from a group of
chronic disease isolates by a variety of biochemical parameters and in a guinea pig fever model of acute disease,
suggesting a difference in virulence potential. We compared antigenic polypeptides among C. burnetii isolates
and found an immunodominant 28-kDa protein in acute group isolates but not in chronic group isolates (T.
Ho, A. Hotta, G. Q. Zhang, S. V. Nguyen, M. Ogawa, T. Yamaguchi, H. Fukushi, and K. Hirai, Microbiol.
Immunol. 42:81-85, 1998). In order to clone the adaA gene, the N-terminal amino acid sequence of adaA was
determined and a 59-bp fragment was amplified from Nine Mile phase I DNA by PCR. The putative gene
fragment was used to screen a lambda ZAP II genomic DNA library, and an open reading frame expressing a
28-kDa immunoreactive protein was identified. Sequence analysis predicted a gene encoding an 28-kDa
mature protein with a typical signal sequence. The adaA (acute disease antigen A) gene was detected in acute
group C. burnetii isolates but not identified in chronic group isolates by PCR and Southern blotting. A typical
signal peptide was predicted in adaA, and specific antibody to adaA reacted with the purified membrane
fraction of acute group isolates by Western blotting, suggesting that adaA is exposed on the outer surface of C.
burnetii. adaA was overexpressed in pET23a as a fusion protein in Escherichia coli to develop anti-recombinant
adaA (anti-radaA) specific antibody, which recognized a 28-kDa band in acute group isolates but not in
chronic group isolates. In addition, immunoblotting indicates that radaA reacted with sera derived from
animals infected with acute group isolates but did not react with sera from animals infected with chronic group
isolates. These results support the idea that an adaA gene-targeted PCR assay and an radaA antigen-based
serodiagnostic test may be useful for differential diagnosis of acute and chronic Q fever.
Coxiella burnetii is an obligate intracellular bacterium that
causes acute and chronic forms of Q fever in humans. Acute Q
fever is an influenza-like illness that usually is self-limiting and
effectively treated by antibiotics (11). In contrast, chronic Q
fever is a severe, sometimes fatal disease, and patients have
responded poorly to various antibiotics (8, 20). Endocarditis is
the most common chronic manifestation, while vascular infec-
tion, bone infection, and chronic hepatitis are also reported
(21). Infection in most animals is mainly subclinical, but abor-
tion and infertility are common manifestations in ruminants
(2). Domestic animals, especially cattle, sheep, and goats, are
important reservoirs of the agent responsible for infection of
humans (7, 11).
C. burnetii has been isolated from various sources including
milk, ticks, and humans with acute and chronic Q fever world-
wide (2, 7, 8, 10). Previous studies have demonstrated that C.
burnetii isolates originating from milk, ticks, and humans with
acute Q fever differ in plasmid type (22), lipopolysaccharide
profiles (3), and chromosomal DNA restriction endonuclease
fragment patterns (5) from many isolates originating from
chronic Q fever. The differences at the phenotypic and molec-
ular levels between acute and chronic disease-associated iso-
lates suggested that there may be a virulence potential char-
acteristic of each group of isolates. Samuel et al. first reported
that C. burnetii isolates associated with acute Q fever contained
the QpH1 plasmid, while isolates associated with chronic Q
fever possessed the QpRS plasmid or the plasmid sequences
were integrated into the chromosome (22, 23). More recent
studies of several C. burnetii isolates from Europe detected
either the QpH1 plasmid-specific sequences (25, 26) or plas-
mid type QpDV (27) in both acute and chronic disease-asso-
ciated isolates, suggesting that there was no specific gene(s) on
plasmids responsible for a specific virulence phenotype. These
data supported the notion that chronic disease could result
from isolates associated with acute disease and might result
from unique patient factors associated with immune status
(25–27). However, no chronic disease-associated organisms
have been isolated from acute Q fever patients. Therefore, it is
quite possible that there are bacterial genetic factors respon-
sible for acute disease. This hypothesis was supported in a
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study by Moos and Hackstadt (17) comparing virulence of a
prototype isolate from each group in guinea pigs. The acute
disease group prototype isolate (Nine Mile phase I RSA493)
caused infection and fever when delivered intraperitoneally
with less than 10 organisms, while the chronic disease group
prototype isolate (Priscilla Q177) required at least 105 organ-
isms to cause fever.
Our previous study identified a 28-kDa protein (P28) that
was immunodominant in isolates originating from milk, ticks,
and humans with acute Q fever but not immunogenic in iso-
lates originating from chronic Q fever (6). This finding sug-
gested that adaA could be associated with a pathogenic factor
of acute Q fever. adaA may also have value as a marker to
distinguish isolate groups. In order to clone and characterize
the adaA-encoding gene, the N-terminal amino acid sequence
of the protein was determined by protein sequencing. A 59-bp
gene fragment was amplified from Nine Mile phase I DNA by
PCR with one primer pair designed based on the N-terminal
amino acid sequence and was used as a probe to screen a
genomic library by Southern hybridization. The gene encoding
P28 was cloned and sequenced. Outer membrane localization
and antigenicity of adaA indicated that adaA may be a viru-
lence factor related to acute Q fever, and the adaA gene may
be a useful genetic marker for differentiation of isolates of C.
burnetii.
MATERIALS AND METHODS
Bacterial strains, phage, and growth conditions. Seventeen C. burnetii isolates
from various clinical and geographical sources were used in this study. The
original source, pathogenic characteristics, and genetic properties of these strains
are summarized in Table 1. All the isolates were propagated in BGM or L929 cell
cultures and purified as described elsewhere (7, 22). The bacteriophage lambda
ZAP II (Stratagene, La Jolla, Calif.) was used as the vector for construction of
the C. burnetii expression genomic DNA library. Escherichia coli XL-Blue MRF
(Stratagene) was cultured in Luria broth (LB) with 12.5 g of tetracycline/ml and
used as the host strain for recombinant plasmids and bacteriophage lambda ZAP
II.
Preparation of C. burnetii OMPs. The outer membrane proteins (OMPs) of C.
burnetii were extracted from purified C. burnetii Nine Mile based on the method
described by Ohashi et al. (19). Briefly, purified organisms were suspended in 10
mM sodium phosphate buffer, pH 7.4, containing 1% Sarkosyl (Sigma, St. Louis,
Mo.) and 50 g each of DNase I and RNase A and incubated at 37°C for 30 min.
EDTA at a final concentration of 15 mM was added to stop the nuclease
reaction. The insoluble precipitates were obtained by centrifugation at 10,000 
g for 1 h, washed twice with 0.1% Sarkosyl–phosphate-buffered saline, and then
resuspended in STE buffer (100 mM NaCl, 10 mM Tris-HCl, and 1 mM EDTA,
pH 8.0) containing 1 mM phenylmethylsulfonyl fluoride (Sigma).
Analysis of the N-terminal amino acid sequences of adaA. The OMPs of C.
burnetii Nine Mile were separated by reversed discontinuous sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically
transferred to a polyvinylidene difluoride membrane as described elsewhere (19).
The presence of adaA in the purified membrane fraction of C. burnetii Nine Mile
was confirmed by immunoblotting as described previously (6). The portion of the
polyvinylidene difluoride membrane containing adaA was excised and analyzed
with the HP G1005A protein sequencing system (Takara Shuzo Co., Kyoto,
Japan).
Preparation of DNA probe specific to the P28-encoding gene. The N-terminal
amino acid sequence of adaA was determined as ENRPILNTINYQQQVEKWV
TTDSADVMVSVN. Based on the N-terminal amino acid sequence, a pair of
primers, P28a (5-ATHAAYTAYCARCARCARGT-3) and P28b (5-AGCAT
NACRTCNGC-3), were designed and used to amplify a 59-bp fragment of the
putative adaA gene. The expected 59-bp product was amplified from C. burnetii
Nine Mile DNA by PCR with these primers. The nucleotide sequence of the
59-bp fragment was determined by the dideoxy nucleotide chain-termination
method as described previously (29). Sequence analysis of the 59-bp fragment
indicates that the deduced amino acid sequence is identical to the chemically
determined N-terminal amino acid sequence of P28, suggesting that the 59-bp
fragment is specific DNA of the adaA gene. Based on the determined nucleotide
sequence, specific primers P28a1 (5-ATTAATTATCAACAGCAGGTTG-3)
and P28b1 (5-AGCATTACATCGGCAGAATCC-3) were designed and used
to amplify the 59-bp specific fragment of the adaA gene from C. burnetii Nine
Mile DNA. The amplified 59-bp fragment was labeled by the random primer
TABLE 1. Original source, pathogenic characteristics, genetic group, and plasmid type of C. burnetii strains
Groupa Plasmidtypeb Isolate
c Phase Original source Disease or type Passaged
I QpH1 Nine Mile RSA493 I Montana, tick, 1935 307GP/1TC/1EP
Turkey RSA333 II Turkey, human blood, 1948 Acute 31EP
African RSA334 (e) I Central Africa, human blood, 1949 Acute, Congolese
red fever
3HP/4EP
Giroud RSA431 (e) I Central Africa, human blood, 1949 Acute, Congolese
red fever
2GP/2EP
El Tayeb RSA342 I Egypt, tick, 1967 4GP/2EP
Panama RSA335 I Panama, chiggers, 1961 4EP
California 33 RSA329 I California, cow’s milk, 1947 Persistent 6EP
Ohio 314 RSA270 I Ohio, cow’s milk, 1956 Persistent 4EP
II Henzerling RSA331 II Italy, human blood, 1945 Acute 36EP
IV QpRS Priscilla I Montana, goat cotyledon, 1980 Abortion GP/2EP
KQ154 I Oregon, human heart valve, 1976 Endocarditis HV/2EP
V NP GQ212 I Nova Scotia, Canada, human heart valve, 1981 Endocarditis HV/2EP
SQ217 I Montana, human liver biopsy sample, 1981 Hepatitis BX/2EP
KoQ229 I Nova Scotia, Canada, human heart valve, 1982 Endocarditis HV/2EP
VI QpDG Dugway 7E22-57 I Utah, rodents, 1958 3EP
—f QpDV MAN I French, human blood Aortic aneurysm ?
—f ME I French, human heart valve Endocarditis ?
a As defined by restriction enzyme banding patterns (5).
b Plasmids were described elsewhere (22, 27).
c Provided by Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Mont. Reference strains were determined by
complement block titration (M. G. Peacock, Rocky Mountain Laboratories).
d Numbers indicate passage number; GP, guinea pig passage; TC, tissue culture; EP, egg passage; HP, hamster passage; HV, heart valve; BX, liver biopsy sample;
?, passage prior to receipt in authors’ laboratory not known.
e , passage history variants.
f —, MAN and ME were not classified (27).
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extension method with the digoxigenin DNA labeling kit (Roche Diagnostics
K. K., Tokyo, Japan) and used as a DNA probe to screen the genomic DNA
library of C. burnetii by Southern hybridization.
Construction and screening of genomic DNA library. A lambda ZAP II
genomic DNA library was constructed as described by Macellaro et al. (9) and
screened by Southern hybridization with the adaA gene-specific probe. Briefly,
the genomic library was plated on E. coli XL-Blue MRF to yield about 500
plaques per plate. Plates were incubated at 37°C until plaques were 1 mm in
diameter. Plaques were transferred onto a nylon membrane (Amersham Phar-
macia Biotech, Piscataway, N.J.) and were hybridized with the adaA gene-specific
probe according to the protocol provided by the manufacturer (Roche Diagnos-
tics K. K.). The positive plaques were detected by using the digoxigenin lumi-
nescent detection kit (Roche Diagnostics K. K.). In vivo excision of the pBlue-
script vector along with the inserted DNA of each positive clone was performed
according to the protocol of the supplier of the lambda ZAP II cloning system.
Immunoblot analysis of adaA expression in E. coli. E. coli containing the
recombinant plasmid was cultured in LB supplemented with 4 mM IPTG (iso-
propyl--D-thiogalactopyranoside) at 37°C overnight, and then cells were pel-
leted by centrifugation. The cell pellet was analyzed by SDS-PAGE and immu-
noblotting with rabbit anti-Nine Mile serum as described previously (30).
DNA sequence analysis. Plasmid DNAs from positive clones that expressed
immunoreactive protein were isolated and purified by using the FlexyPrep kit
(Amersham Pharmacia Biotech). The nucleotide sequence was partially deter-
mined by the dideoxy nucleotide chain-termination method with the Thermo
Sequenase Cy5.5 dye terminator cycle sequencing kit and SEQ4x4 personal
sequencer system (Amersham Pharmacia Biotech). A BLAST search against the
complete genomic sequence of Nine Mile phase I (24) was achieved to identify
the complete nucleotide sequence of the cloned gene. The nucleotide sequence
and the deduced amino acid sequence were analyzed by the GENETYX ana-
lyzing system (Software Development Co., Ltd., Tokyo, Japan).
Detection of the adaA gene from various isolates of C. burnetii by PCR. A pair
of primers, P28F and P28R, was designed based on the adaA gene sequence and
used to amplify a 269-bp fragment (ranging from positions 369 to 637 in the open
reading frame [ORF] region of the adaA gene) from DNAs of 17 isolates from
various clinical and geographical sources. The sequences of the primers are as
follows: P28F, 5-AATAGATTCGCTCTCTCAAGCCG-3, and P28R, 5-TCA
CCGCTGTTTTTTCAGACG-3. PCR was performed with 2.5 U of Taq DNA
polymerase (Invitrogen, Carlsbad, Calif.) in 50 l of reaction mixture containing
20 ng of genomic DNA, 0.2 M (each) primer, and 200 M (each) deoxynucle-
otide triphosphates in 10 mM Tris-HCl (pH 8.3)–50 mM KCl–2.5 mM MgCl2.
The reactant was subjected to 35 cycles of 30 s at 94°C, 30 s at 53°C, and 1 min
at 72°C in a DNA thermal cycler (PTC-0200 DNA Engine; MJ Research, Inc.,
Waltham, Mass.).
Southern blotting. Restriction enzyme-digested DNAs from various clinical
phenotypic isolates including two acute prototypic isolates (Nine Mile and Hen-
zerling) and five chronic prototypic isolates (Priscilla, Q217, Q229, MAN, and
ME) were tested by Southern blotting with the adaA gene-specific probe.
Expression and purification of the adaA fusion protein. The 602-bp DNA
fragment of the adaA gene was amplified from C. burnetii Nine Mile DNA by
PCR with primers P28EF-P28ER, which were designed from the adaA gene
sequence and included 602 bp of the ORF region without the signal peptide-
encoding sequence. Primer P28EF (5-TTCGCTGCCACCGGATCCTTC-3) is
the 5 end of the adaA gene with an additional BamHI restriction site, and
primer P28ER (5-ATCAACTCGAGGTTTCTTCG-3) is complementary to the
3 end of the gene with a XhoI restriction site in the sequence. The amplified
adaA gene fragment was digested with BamHI and XhoI, ligated to expression
vector pET23a, and then transformed into E. coli BL21(DE3)LysS competent
cells. Expression of T7-tagged (N-terminal) and His-tagged (C-terminal) recom-
binant adaA (radaA) was induced by 4 mM IPTG. radaA was purified by using
a ProBond resin column (Invitrogen) under denaturing conditions.
Antiserum preparation and immunoblot analysis of adaA among various
strains of C. burnetii. The anti-adaA specific antibody was produced by immu-
nization of BALB/c mice with purified radaA. Briefly, BALB/c mice (6 weeks
old) were immunized with purified recombinant fusion protein in adjuvant (Ti-
termax) three times at 14-day intervals. At each immunization, mice were sub-
cutaneously injected with 50 l of antigen (containing 20 g of radaA) mixture
with 50 l of Titermax. After the third immunization, serum was collected and
stored at 20°C.
The expression of adaA in various strains of C. burnetii was confirmed by
immunoblotting with anti-adaA specific serum. SDS-PAGE and immunoblotting
were performed as described elsewhere (31).
Reactivity of purified radaA with infection-derived sera. The reactivity of
radaA with sera from guinea pigs infected with various strains of C. burnetii was
analyzed by immunoblotting. Guinea pig serum was collected at 4 weeks post-
aerosol infection with 106 organisms of the Nine Mile phase I, Ohio, Q217, or
Q229 strain and stored at80°C until use. C. burnetii Nine Mile whole-cell lysate
and purified rCom1, which is a protein common to all isolates tested (29, 30),
were used as a control to confirm the presence of the antibodies to C. burnetii
antigens in infection-derived sera. SDS-PAGE and immunoblotting were per-
formed as described previously (31).
RESULTS
Cloning the adaA gene. Immunoblotting identified an immu-
noreactive band at 28 kDa in the purified membrane fraction
of C. burnetii Nine Mile but did not detect reactivity in the
Q217 strain (Fig. 1). The result confirmed that the 28-kDa
protein corresponds to the adaA previously noted (6). To iden-
tify the adaA gene, we determined the N-terminal 31 amino
acids of a 28-kDa protein from C. burnetii Nine Mile. Based on
the amino acid sequence, we designed several primer pairs and
successfully amplified a 59-bp fragment from C. burnetii Nine
Mile DNA by PCR. The 59-bp fragment was used as a DNA
probe to screen a genomic library of C. burnetii Nine Mile
DNA. Approximately 10,000 plaques were screened by South-
ern hybridization with the adaA gene-specific probe. Forty
positive plaques were purified and compared for expression of
immunoreactive proteins. Coomassie brilliant blue (CBB)
staining on an SDS-polyacrylamide gel identified one clone,
designated p110, expressed as an 24-kDa protein. Immuno-
blotting indicates that the protein expressed by clone p110
reacted with rabbit anti-Nine Mile serum (data not shown),
suggesting that the clone p110-expressed recombinant protein
is specific for C. burnetii.
Sequence analysis. To determine the nucleotide sequence of
the ORF encoding adaA, the purified recombinant plasmid
from clone p110 was sequenced. The adaA gene-specific prim-
ers P28a1 and P28b1 were used in a sequence reaction to
directly determine the nucleotide sequence of the adaA gene.
The sequence of the p110 cloned insert was BLAST searched
against the complete genome sequence of C. burnetii Nine Mile
RSA493, allowing confirmation of the nucleotide sequence of
FIG. 1. Immunoblot analysis of purified OMPs of Nine Mile and
Q217 strains with rabbit anti-Nine Mile hyperimmune serum. Lane 1,
Nine Mile; lane 2, Q217.
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the cloned gene (24). The nucleotide sequence (1,240 bp) from
the cloned gene is shown in Fig. 2, which includes the flanking
regions and the deduced amino acid sequence of P28. The
adaA gene has a predicted ORF consisting of 684 bp, starting
with an ATG codon at position 264 and ending with a TAG
codon at position 947. The ORF is preceded by a putative
ribosome-binding site, GGAGG, from 7 bp upstream of the
ATG start codon. A predicted promoter sequence, TTGAA
T-21 nt-TGTTAT, was found 36 bp upstream from the puta-
tive ribosome-binding site. The GC content of the ORF
coding region was 40%, which is similar to the value of C.
burnetii total genomic GC content (43%). The predicted
mature P28 protein consists of 227 deduced amino acid resi-
dues and has a calculated molecular mass of 25,950 Da and a
theoretical isoelectric point of 8.60. A 20-amino-acid signal
peptide was also predicted for the N-terminal sequence of
adaA. We also confirmed that the chemically determined N-
terminal 31 amino acids of adaA were identical to the amino
acid sequence of the mature protein deduced from the nucle-
otide sequence of the cloned adaA gene, which is the region
immediately adjacent to a predicted signal peptide (Fig. 2). In
addition, a BLAST search of GenBank with the deduced
amino acid sequence of the adaA gene indicated that the ORF
encoding adaA was identical to CBU0952, which was predicted
by The Institute for Genomic Research gene annotation (24).
These results suggest that the ORF identified in the p110
cloned gene sequence is a gene unique to C. burnetii and
encodes adaA.
Detection of the adaA gene in various isolates of C. burnetii.
PCR and Southern blotting were used to test and confirm
FIG. 2. Nucleotide sequence of the adaA gene. The deduced amino acid sequence is shown beneath the nucleotide sequence of the ORF. A
putative promoter (positions 35 and 10) is underlined (thin line). The predicted ribosome-binding site (RBS) is underlined (thick line). The
20-amino-acid sequence at the N-terminal end of adaA is predicted to be a signal peptide. The chemically determined N-terminal 31-amino-acid
sequence was identical to the N-terminal end of the deduced amino acid sequence of adaA.
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whether the adaA gene is unique for a subgroup of isolates.
The PCR result indicated that the adaA gene-specific fragment
was amplified from isolates originating from humans with
acute Q fever, ticks, cattle, and rodents, but PCR did not
amplify any product from isolates from goats or humans with
chronic Q fever (Fig. 3). Southern blotting also indicated that
the adaA gene-specific probe hybridized with one band with
SalI-digested DNAs of Nine Mile and Henzerling strains as-
sociated with acute Q fever but did not hybridize with any band
with SalI-digested DNAs of Priscilla, Q217, Q229, MAN, and
ME strains, which have been linked to chronic Q fever (data
not shown). These results suggest that the adaA gene is specific
for C. burnetii isolates originating from humans with acute Q
fever, ticks, cattle, and rodents.
Expression of adaA in E. coli and various isolates of C.
burnetii. The partial adaA protein of the Nine Mile strain was
overexpressed as a fusion protein in pET23a. An IPTG-induc-
ible fusion protein with a molecular mass of 28 kDa was de-
tected in the adaA gene recombinant pET23a-transformed E.
coli culture by CBB staining of the SDS-polyacrylamide gel and
immunoblotting with a His-tagged specific monoclonal anti-
body (Fig. 4A and B, lanes 2 and 3). The expressed fusion
protein was not detected in the negative control of pET23a-
transformed E. coli culture (Fig. 4A and B, lanes 1). SDS-
PAGE and immunoblotting also indicated that radaA was suc-
cessfully purified from the adaA gene recombinant pET23a-
transformed E. coli culture by using ProBond resin column
(Fig. 4A and B, lanes 4). To confirm that P28 is expressed by
acute disease isolates but not carried by chronic disease iso-
lates, anti-radaA specific antibody was produced and used in
immunoblotting with antigens of various strains of C. burnetii.
Immunoblotting indicated that a 28-kDa reaction band was
detected from acute-disease-associated isolates Nine Mile and
Henzerling but not observed in chronic-disease-associated iso-
lates Priscilla and Q217 (Fig. 4C). This result confirmed that
our cloned adaA gene encodes adaA and that adaA is ex-
pressed by acute-disease-associated isolates but not carried by
chronic-disease-associated isolates.
Reactivity of purified radaA with sera derived from infected
animals. Figure 5 shows the immunoblots of the whole-cell
antigen, rCom1, and radaA with sera derived from a guinea pig
FIG. 3. Detection of the adaA gene from various isolates of C.
burnetii by PCR with primers P28F-P28R. Shown is an ethidium bro-
mide-stained agarose gel electrophoretogram of PCR-amplified prod-
ucts. Lane 1, molecular size markers (100-bp DNA ladder); lanes 2 to
9, isolates originating from ticks, milk, and humans with acute Q fever
(Nine Mile, Ohio, California, El Tayeb, Africa, Panama, Turkey, and
Giround, respectively); lanes 10 to 14, isolates originating from a goat
and humans with chronic Q fever (Priscilla, KQ154, KoQ229, SQ217,
and GQ212, respectively); lane 15, Dugway isolate.
FIG. 4. Expression of the adaA gene in the pET23a expression
vector system. Expression of the T7-tagged (N-terminal) and His-
tagged (C-terminal) fusion protein was monitored by CBB staining of
uninduced and induced cultures by SDS-PAGE and immunoblotting
with His-tag-specific monoclonal antibody. (A) CBB staining profile of
the expressed and purified fusion adaA protein. Lane M, molecular
size markers; lane 1, pET23a-transformed E. coli (negative control);
lanes 2 and 3, adaA gene recombinant pET23a-transformed E. coli
uninduced and induced cultures, respectively; lane 4, purified fusion
radaA. (B) Immunoblot analysis of expressed and purified recombi-
nant proteins with His-tag-specific monoclonal antibody. The samples
shown in panel B are the same as in panel A. (C) Immunoblot analysis
of adaA in various strains of C. burnetii with adaA-specific antiserum.
Lanes 1 to 4, whole-cell lysate of Nine Mile, Henzerling, Priscilla, and
Q217 strains, respectively. A 28-kDa reaction band was observed in
acute disease isolates including the Nine Mile and Henzerling strains
but not detected in Priscilla and Q217. Numbers at left are molecular
masses in kilodaltons.
FIG. 5. Immunoblots of whole-cell antigen, rCom1, and radaA with
sera derived from guinea pigs 4 weeks post-aerosol infection with 106
organisms of either the acute or the chronic prototypic isolate of C.
burnetii. Sera (diluted 1:500) came from guinea pigs infected with Nine
Mile (A), Ohio (B), Q217 (C), and Q229 (D). The samples shown in
panels A to D are the same. Lanes 1, Nine Mile whole-cell antigen;
lanes 2, purified rCom1 protein; lanes 3, purified recombinant adaA
protein. Numbers at left are molecular masses in kilodaltons.
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4 weeks post-aerosol infection with 106 organisms of the acute
or chronic prototypic strain of C. burnetii. All sera from guinea
pigs aerosol infected with 106 organisms of various strains
strongly reacted with Nine Mile whole-cell antigen at a wide
range of molecular weights and with rCom1 at similar levels
(Fig. 5, lanes 1 and 2). However, radaA reacted with sera from
guinea pigs infected with isolates Nine Mile and Ohio (Fig. 5A
and B, lanes 3) but not with sera from those infected with
isolates Q217 and Q229 (Fig. 5C and D, lanes 3). These results
indicate that anti-adaA specific antibody was present in sera
derived from animals infected with the acute prototypic isolate
but absent in sera from animals infected with the chronic
prototypic isolate.
DISCUSSION
Cloning and characterization of adaA demonstrated that this
protein is specific for acute-Q-fever-related isolates but de-
leted in chronic-disease-associated isolates despite geographi-
cal source, suggesting that adaA may be a virulence factor
involved in the pathogenesis of acute Q fever in humans.
The predicted adaA mature protein consists of 227 amino
acids and has a predicted molecular mass of 25,950 Da. This is
very close to the molecular size of native adaA expressed in C.
burnetii but about 2 kDa larger than the expression product of
the adaA gene in E. coli (data not shown). The 25-amino-acid
signal peptide is predicted in the N-terminal sequence of adaA,
which is probably cleaved from the mature protein when the
adaA gene is expressed in E. coli. The chemically determined
N-terminal and internal peptide (data not show) amino acid
sequences of adaA were identical to the deduced amino acid
sequence of the cloned adaA gene, confirming that the iden-
tified ORF encodes adaA. The cloned adaA gene recombinant
pUC19 expressed radaA in E. coli DH5	 cells without induc-
tion by IPTG (data not shown). A potential promoter se-
quence, TTGAAT-21 nt-TGTTAT, was identified in the adaA
gene sequence, suggesting that the adaA gene was expressed in
E. coli by using the endogenous promoter. A BLAST search of
GenBank with either the nucleotide sequence or the deduced
amino acid sequence for the adaA gene did not identify signif-
icant DNA or amino acid homologies, suggesting that adaA is
unique to C. burnetii.
OMPs of gram-negative bacteria are employed in several
important roles in the host-parasite interaction and relate to
both pathogenesis and protective immunity. Due to the diffi-
culties in cultivation and purification of C. burnetii, only a
limited group of OMP-encoding genes have been character-
ized (4, 16, 28). Candidates for OMPs include the QpH1 plas-
mid-specific gene cbhE for a 42-kDa surface protein (15) and
the QpRS plasmid-specific gene cbbE for a 55-kDa surface
protein (12–14), which have been speculated to be virulence
related and associated with acute or chronic Q fever in hu-
mans. However, recent investigations of several European iso-
lates suggested that there were no specific genes on plasmids
responsible for acute or chronic Q fever (25–27) and supported
the notion that host factors may play a key role in the devel-
opment of chronic Q fever. It remains unknown whether there
are specific genes on the chromosome responsible for acute or
chronic Q fever. Isolates from acute disease are distinct from
chronic-disease-associated isolates at the molecular level (3, 5,
22) and in a guinea pig fever model of acute disease (17; K.
Russell, unpublished data), suggesting different virulence po-
tentials for groups of isolates of C. burnetii. In this study, we
identified a novel 28-kDa membrane-associated protein and
demonstrated that adaA is expressed in acute group isolates
but not carried by chronic group isolates, suggesting that adaA
may be a virulence factor related to acute Q fever. Immuno-
blotting with purified radaA antigen recognized anti-adaA spe-
cific antibody from sera derived from animals infected with
acute group isolates but not from sera from animals infected
with chronic group isolates, suggesting that adaA is an impor-
tant antigen in acute disease. Since there has been no suitable
animal model developed to represent the manifestation of
chronic Q fever and because there is a lack of genetic tools for
C. burnetii, it is not possible to directly test whether a specific
gene is related to acute or chronic disease. Recently, SCID
mice have been used as a model highly sensitive to lethal
challenge by an acute-disease-associated isolate of C. burnetii
(1), and preliminary comparison in this model shows dramatic
differences in disease from isolates which do not carry adaA
(M. Andoh, unpublished data). Further studies to test whether
the adaA gene can be delivered on a stable plasmid to a
adaA-negative isolate may allow its role in virulence to be
determined.
Since prompt antibiotic therapy could lead to a better prog-
nosis for individual patients with chronic Q fever, developing a
diagnostic method for rapid differential diagnosis of acute and
chronic Q fever could be very important for control of chronic
disease. Recently, based on point mutations unique to isolate
groups, com1 and icd genes have been used as genetic markers
to distinguish acute and chronic isolates (18, 29). However,
comparison of nucleotide sequences of com1 and icd genes
among isolates indicates that they are highly conserved be-
tween acute and chronic isolates, except for these few point
mutations (18, 29). The finding that the adaA protein and the
adaA gene are unique to acute group isolates can be used for
development of radaA antigen-based serodiagnostic methods
and/or an adaA gene-targeted PCR assay for differential diag-
nosis of acute and chronic Q fever in clinical samples. We have
designed primers based on the nucleotide sequence of the
adaA gene and used them to amplify products from DNA of
various strains of C. burnetii. Amplicon products were ampli-
fied from DNA templates of isolates originating from humans
with acute Q fever, ticks, cattle, and rodents but not from
isolates originating from humans with chronic Q fever, sug-
gesting that PCR for the adaA gene can be used for differen-
tiation of acute- and chronic-disease-associated isolates. In
addition, immunoblotting indicated that radaA reacted with
sera derived from animals infected with acute group isolates
but was not recognized by sera derived from animals infected
with chronic group isolates, suggesting that an radaA antigen-
based serodiagnostic test may be useful for differential diag-
nosis of acute and chronic Q fever in human sera. Further
studies will evaluate the usefulness of an adaA gene-targeted
PCR assay and an radaA antigen-based enzyme-linked immu-
nosorbent assay for differential diagnosis of acute and chronic
Q fever in clinical samples from acute and chronic Q fever
patients.
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